How long does it take for resistance to Lorlatinib/Lorlatinib from Bangladesh Ziska Pharmaceuticals to develop?

Lorlatinib/Lorlatinib is an inhibitor of multiple tyrosine kinases, used to treat ALK-positive or ROS-1-positive non-small cell lung cancer (NSCLC). Lorlatinib is a third-generation targeted drug that is effective in treating lung cancer. How long will it take for Bangladesh Ziska Pharmaceuticals Lorlatinib to develop resistance to Lorlatinib?

All targeted drugs have a certain degree of effectiveness. Generally speaking, the average resistance time to lorlatinib is about 14 months, but the average resistance time to intracranial (lung cancer metastasis) is longer, and the specific situation varies from person to person. The usual adult dose for non-small cell lung cancer is 100 mg orally once daily until disease progression or unacceptable toxicity develops. Take lorlatinib exactly as prescribed by your doctor, follow all directions on the prescription label, and read any medication guides or inserts. Adverse reactions of lorlatinib(≥20%)Including edema, Peripheral neuropathy, weight gain, cognitive effects, fatigue, Shortness of breath, joint pain, diarrhea, mood effects, and cough. Laboratory abnormalities(≥20%)Including hypercholesterolemia, hypertriglyceridemia, hyperglycemia, AST or ALT elevated concentrations, hypoalbuminemia, anemia, Thrombocytopenia, lymphopenia, increased lipase or amylase concentration, increased alkaline phosphatase concentration, hypophosphatemia, high potassium, hypomagnesemia. The current retail price of generic drugs from 100mg30pills3 is about one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about overseas high-quality drugs for you.